 |
|
Genetic variation impacts aspirin's effectiveness in preventing colon cancer, Dartmouth study finds
October 25, 2006Dartmouth researchers are among a team of doctors that have learned more about how people may or may not benefit from taking aspirin in the effort to curb colon cancer. Their study, which appears in the Oct. 18 issue of the Journal of the National Cancer Institute, finds that the beneficial effect of aspirin may be limited to individuals who have a specific genetic variation in their ODC gene.
"There is evidence that aspirin and related anti-inflammatory drugs can reduce the risk of colorectal adenomas [polyps] and cancer," says Elizabeth Barry, a research assistant professor of community and family medicine at Dartmouth Medical School, and one the authors of the study. "And with this study, we looked closer at the impact of aspirin in people who have a higher risk of developing colorectal adenomas, which lead to cancer, by examining their ODC genotype. So now we know that aspirin appears to work better in people who have this slight genetic variation, and this finding could potentially be clinically useful in the future by allowing physicians to predict which individuals are likely to benefit from aspirin use for colorectal cancer chemoprevention."
The researchers studied 973 subjects over three years as part of the Aspirin/Folate Polyp Prevention Study. In a randomized manner, some were given aspirin and some were given placebos. Almost half of the participants carried one or two copies of the ODC genetic variation. The study found that there was no association between carrying the genetic variation and the occurrence or new adenomas, but the genotype did influence the effect of aspirin on adenoma development. Those with the ODC genetic variation were 23 percent less likely to develop new adenomas and 49 percent less likely to develop more advanced lesions, which also lead to cancer.
Other authors on the paper include John A. Baron and Maria V. Grau, with Dartmouth Medical School; Shubha Bhat and Thomas G. O'Brien, with the Institute for Medical Research in Wynnewood, Penn.; Carol A. Burke, with the Cleveland Clinic Foundation; Robert S. Sandler, with the University of North Carolina; Dennis J. Ahnen, with the University of Colorado Health Sciences Center in Denver; and Robert W. Haile, with the University of Southern California, Los Angeles.
This study was funded by the National Cancer Institute.
Dartmouth College
Other authors on the paper include John A. Baron and Maria V. Grau, with Dartmouth Medical School; Shubha Bhat and Thomas G. O'Brien, with the Institute for Medical Research in Wynnewood, Penn.; Carol A. Burke, with the Cleveland Clinic Foundation; Robert S. Sandler, with the University of North Carolina; Dennis J. Ahnen, with the University of Colorado Health Sciences Center in Denver; and Robert W. Haile, with the University of Southern California, Los Angeles.
This study was funded by the National Cancer Institute.
Dartmouth College
Aspirin Current Events and Aspirin News RSSEarly end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature
Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing.
Common Pain Relievers May Dilute Power of Flu Shots
With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers - Advil, Tylenol, aspirin - at the time of injection may blunt the effect of the shot and have a negative effect on the immune system.
News brief: Effects of aspirin and folic acid on inflammation markers for colorectal adenomas
Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute.
Aspirin Misuse May Have Made 1918 Flu Pandemic Worse
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin.
Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine
Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors (PPIs), did not lead to adverse events, as some prior studies had suggested.
Aspirin works for primary prevention in moderate and high risk diabetics
The beneficial effects of aspirin in primary prevention of cardiovascular events i.e. stroke, MI and cardiac death are known and generally accepted.
New strategies for reperfusion therapy
A new trial has begun in order to ascertain once and for all whether the best strategy for patients who cannot receive P-PCI is early fibrinolysis, together with mandated angiography.
Small peptide found to stop lung cancer tumor growth in mice
In new animal research done by investigators at Wake Forest University School of Medicine, scientists have discovered a treatment effective in mice at blocking the growth and shrinking the size of lung cancer tumors, one of the leading causes of cancer death in the world.
Genetic variation associated with poorer response, cardiovascular outcomes with use of clopidogrel
Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) had an increased risk of having a cardiovascular event in the following year than patients who did not have this variant, according to a study in the August 26 issue of JAMA.
Study reveals mounting evidence of fish oil's heart health benefits
There is mounting evidence that omega-3 fatty acids from fish or fish oil supplements not only help prevent cardiovascular diseases in healthy individuals, but also reduce the incidence of cardiac events and mortality in patients with existing heart disease.
More Aspirin Current Events and Aspirin News Articles
 |
Bayer Low Dose 81 mg Aspirin Regimen-400 Tablets by Bayer Safety Coated "Baby" Aspirin - Aspirin Regimen For Adult Use * Often Recommended as "Baby" Aspirin by Doctors for Adult Aspirin Regimen Use * Small, Easy-To-Swallow Tablets * Safety Coated for Added Stomach Protection * Aspiring Protects Your Heart by Keeping Your Blood Flowing Freely For the temporary relief of minor aches and pains or as recommended by your doctor. Because of its delayed action, this product will not provide fast relief of headaches or other symptoms needing immediate relief. Ask your doctor about other uses for Safety Coated 81 mg Aspirin. |
 |
Member's Mark - Aspirin 81 mg, Adult Low Strength, 500 Tablets, Compare to St. Joseph's by Sam's West, Inc. 500 tablets |
 |
Low Dose Aspirin (enteric coated) 81mg 500 Tablets by Life Extension Numerous studies document the multiple health benefits of daily low dose aspirin. Aspirin helps to maintain normal platelet aggregation in blood vessels and the production of prostaglandin E2 and possibly C-reactive protein. |
 |
Equate - Aspirin 325 mg, Original Strength, 500 Coated Tablets, Pain Reliever (Compare to Buyer) by Perrigo. |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, 300-Count Coated Tablets (Pack of 2) by Bayer Pain Reliever/Fever Reducer. Fast, safe pain relief Plus the life saving benefits of aspirin. Headaches; Everyday aches and pains. Doctor recommended for Aspirin Regimen Use. Aspirin is not appropriate for everyone, so be sure to talk to your doctor befor |
 |
KS Enteric Coated Aspirin 81 mg Tablets - Adult Low Strength Regimen - Compare to the Active Ingredients in Bayer Enteric Coated Low Strength Aspirin - 730 ct. by Kirkland Signature Read all instructions and warnings before taking this or any other medication. |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, Low Dose Safety Coated for Baby (81 mg), 200-Count Enteric Coated Tablets (Pack of 2) by Bayer It is most often used by patients who are taking aspirin on a regular basis under a doctor's supervision. This product contains one-quarter the medicine of a regular strength aspirin tablet allowing you to more conveniently take the dosage directed by you |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, Extra Strength PLUS, 50-Count Caplets (Pack of 4) by Bayer Aspirin PLUS a "Buffer" to guard against upset stomach, Use for the temporary relief of headache, muscle pain, toothache, pain and fever of colds, menstrual pain, minor pain of arthritis |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, Extra Strength Back & Body Pain, 100-Count Caplets (Pack of 2) by Bayer Fast, Safe Pain Relief. Safely relieves tough pain Coated for easier swallowing Ask you doctor about the benefits of other Bayer® Aspirin products |
 |
BOTTLED ASPIRIN 1000/BOTTLE by GERI-CARE PHARMACEUTICALS 5 grain USP aspirin. Low cost generic bottled pain relief. 1000 tablets per bottle. |
| © 2009 BrightSurf.com |